Seeking Profit for Taxpayers in Potential of New Drug

Federal Science - it has become a controversial topic since the Great Recession. Many lawmakers are calling for a review of federal policies they say have allowed businesses to profit on government research with limited return for taxpayers or consumers. Taxpayers are asking the government to reevaluate the funding provided for federal research into pharmaceutical drugs. I can understand this concern from taxpayers. In such tough economic times, people want their money put to good use. It can be frustrating to see funding fail to present any productive results.